Data Safety Monitoring Board: This independent committee will be comprised of one emergency physician, one cardiologist and a biostatistician from outside the participating sites. This board will be responsible for safeguarding the interests and safety of trial participants by reviewing adverse events including deaths every 6 months during the study period.